Sima disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Classification== | ==Classification== | ||
{| class="wikitable" | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
! | |||
!Disease | |||
!laboratory | |||
! | |||
! | |||
|- | |||
|Type 1 | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Type 2 | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|Type 2B | |||
| | |||
| | |||
| | |||
| | |||
|} | |||
====Type 2A, ==== | ====Type 2A, ==== | ||
[[Diabetes mellitus|Diabetes]], [[Hypertension|HTN]], Stroke | [[Diabetes mellitus|Diabetes]], [[Hypertension|HTN]], Stroke | ||
*male | *male |
Revision as of 17:49, 29 January 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]Mahshid Mir, M.D. [3]
Overview
hjgefjkgefkefkj
Classification
Disease | laboratory | |||
---|---|---|---|---|
Type 1 | ||||
Type 2 | ||||
Type 2B |
Type 2A,
- male
- female
- African-American
- White